Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2002 | 12-2001 | 09-2001 | 06-2001 | 03-2001 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 95,303 | 150,236 | 108,140 | 65,398 | 26,750 |
| Depreciation Amortization | 67,925 | 428,091 | 318,895 | 212,312 | 105,954 |
| Income taxes - deferred | 416 | 29,357 | 20,834 | 16,283 | 34,526 |
| Accounts receivable | -33,787 | -59,512 | -40,715 | -17,435 | -10,546 |
| Other Working Capital | -86,777 | -127,023 | -127,784 | -130,705 | -134,450 |
| Other Operating Activity | 23,528 | 59,478 | 38,396 | 14,208 | 9,807 |
| Operating Cash Flow | $66,608 | $480,627 | $317,766 | $160,061 | $32,041 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -72,078 | -213,351 | -118,753 | -85,668 | -36,324 |
| Purchase Of Investment | -346,556 | -1,565,060 | -1,032,999 | -833,700 | -275,636 |
| Sale Of Investment | 356,517 | 1,084,546 | 696,500 | 576,144 | 277,157 |
| Other Investing Activity | -7,982 | -10,105 | -61,106 | -57,736 | -2,038 |
| Investing Cash Flow | $-70,099 | $-703,970 | $-516,358 | $-400,960 | $-36,841 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 26,964 | 106,866 | 73,771 | 63,083 | 35,355 |
| Common Stock Repurchased | -179,855 | -39,704 | -34,034 | N/A | N/A |
| Other Financing Activity | -149,692 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $-302,583 | $67,162 | $39,737 | $63,083 | $35,355 |
| Beginning Cash Position | 395,203 | 551,384 | 551,384 | 551,384 | 551,384 |
| End Cash Position | 89,129 | 395,203 | 392,529 | 373,568 | 581,939 |
| Net Cash Flow | $-306,074 | $-156,181 | $-158,855 | $-177,816 | $30,555 |
| Free Cash Flow | |||||
| Operating Cash Flow | 66,608 | 480,627 | 317,766 | 160,061 | 32,041 |
| Capital Expenditure | -72,078 | -213,351 | -118,753 | -85,668 | -36,324 |
| Free Cash Flow | -5,470 | 267,276 | 199,013 | 74,393 | -4,283 |